Patents : |  |
| US Patent No. | Title |
| 7473247 | Intradermal delivery of vaccines and gene therapeutic agents via microcannula
|
| 7521421 | Deuterated cyclosporine analogs and methods of making the same
|
| 7521422 | Use of aspartic proteases in cosmetics and therapeutics
|
| 7528168 | Inhibitors of the fatty acid oxidation for the prophylaxis and/or the treatment of chronic and/or atopic skin diseases
|
| 7537919 | Cytochrome P450RAI-2 and related proteins
|
| 7538189 | Methods of making deuterated cyclosporin analogs
|
| 7541362 | Heterocyclic dihydropyrimidine compounds
|
| 7544366 | Method and skin cleansing compositions for dermatological basic treatment
|
| 7544518 | Rapid quantitative analysis of proteins or protein function in complex mixtures
|
| 7547454 | Hydroxy acid complexes for antiaging and skin renovation
|
| 7547766 | Anti-tango294 antibodies and uses thereof
|
| 7517907 | Pharmaceutical/cosmetic compositions comprising a novel RARbeta receptor-activating ligand
|
| 7517890 | GTPase inhibitors and methods of use
|
| 7507839 | Therapeutic ion channel blocking agents and methods of use thereof
|
| 7473422 | Antibodies to retinoid metabolizing protein
|
| 7473541 | Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A.sub.2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities
|
| 7476661 | Regulators of the hedgehog pathway, compositions and uses related thereto
|
| 7479504 | Edg receptor agonists
|
| 7482147 | Ubiquitin protease
|
| 7483738 | Combination stimulating and exothermic heating device and method of use thereof
|
| 7485308 | 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
|
| 7485315 | Compositions comprising a compound of low solubility and a lipophilic amino acid derivative, uses thereof and process for dissolving a compound of low solubility
|
| 7501121 | IL-13 binding agents
|
| 7507730 | Substituted pyrazolo[1,5-a]pyrimidines as potassium channel activators
|
| 7557127 | HDAC inhibitor
|
| 7560462 | Compounds useful for inhibiting CHK1
|
| 7598060 | Rapid analysis of variations in a genome
|
| 7601335 | Pretreatment of a biological sample from an autoimmune disease subject
|
| 7604812 | Hypoallergenic and non-irritant skin care formulations
|
| 7605171 | (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
|
| 7608638 | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
|
| 7611839 | Methods for diagnosing RCC and other solid tumors
|
| 7611851 | Canis sphingosine 1-phosphate receptor isoform 1
|
| 7611879 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
|
| 7615213 | Antibodies against human interleukin-13 and pharmaceutical compositions thereof
|
| 7615349 | Melanoma gene signature
|
| 7597899 | Compositions comprising a combination of a free sphingoid base and ceramide and uses thereof
|
| 7592478 | Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
|
| 7588783 | Flavonoid derivative
|
| 7566455 | E6AP-binding proteins
|
| 7570992 | Electrical field therapy with reduced histopathological change in muscle
|
| 7572776 | N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
|
| 7575764 | Compositions comprising hypsizygus ulmarius extract
|
| 7579329 | P450RAI-2 (P450 cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof
|
| 7579352 | Retinoic acid mimetic anilides
|
| 7582307 | Dermatological composition
|
| 7582654 | Heterocyclo inhibitors of potassium channel function
|
| 7582663 | Biaromatic compounds which activate PPAR.gamma. type receptors and cosmetic/pharmaceutical compositions comprised thereof
|
| 7585645 | Thioredoxin and thioredoxin reductase containing oil body based products
|
| 7615546 | Topical delivery system for phytosterols
|
